Top

Published in:

Open Access 01-12-2017 | Original Article

Osteopenia and the physical function in Japanese patients with schizophrenia

Authors: Satoru Uchida, Tsuyoshi Ichinose, Yoichi Iizuka, Koichi Okamura, Hitoshi Shitara, Manabu Yamazaki, Kenji Takagishi, Haku Iizuka

Published in: Archives of Osteoporosis | Issue 1/2017

Abstract

Summary

We evaluated the state of osteopenia and the physical function in 121 schizophrenic patients. These factors were worse in the inpatient group than in the outpatient group. The age, sex, body mass index (BMI), and physical function were correlated to the state of osteopenia. Physicians should consider the risk of osteopenia in elderly female psychiatric patients with low BMI.

Purpose

Information about the actual state of osteopenia in patients with schizophrenia is limited. In the present study, we evaluated the factors related to osteopenia and patient’s physical function and compared these factors between inpatients and outpatients.

Methods

A total of 121 schizophrenic patients were included in the present study. We divided the patients into two groups according to the therapeutic form. We collected data on their age, sex, body mass index (BMI), bone mineral density (BMD) in the lumbar spine and proximal femur, serum bone metabolic markers, risk of fracture, and physical function.

Results

The number of fractured vertebrae, risk of fracture, serum concentration of tartrate-resistant acid phosphatase 5b (TRACP-5b), and score of locomo25 were significantly higher and the BMI and BMD in the lumbar spine and proximal femur significantly lower in the inpatient group than in the outpatient group. A multiple regression analysis showed that the age, sex, BMI, the number of fractured vertebrae, and score of locomo 25 were correlated with the BMD in the lumbar spine and proximal femur. Neither the therapeutic form nor any bone metabolic markers were correlated with the BMD. The inpatient group had a lower average BMI, BMD, and physical function than the outpatient group. However, a multiple regression analysis showed that the therapeutic form was not correlated with the BMD.

Conclusion

These findings suggest that physicians should consider elderly female schizophrenic patients with a low BMI to be at risk of developing osteopenia.

Raisz LG (2005) Pathogenesis of osteoporosis: concepts, conflicts, and prospects. J Clin Invest 115:3318–3325CrossRefPubMedPubMedCentral

Forwood MR, Turner CH (1995) Skeletal adaptations to mechanical usage: results from tibial loading studies in rats. Bone 17:197S–205SPubMed

Frost HM (2003) Bone's mechanostat: a 2003 update. Anat Rec A Discov Mol Cell Evol Biol 275:1081–1101CrossRefPubMed

Hakestad KA, Nordsletten L, Torstveit MK, Risberg MA (2014) Postmenopausal women with osteopenia and a healed wrist fracture have reduced physical function and quality of life compared to a matched, healthy control group with no fracture. BMC Womens Health 14:92CrossRefPubMedPubMedCentral

Mudge AM, O'Rourke P, Denaro CP (2010) Timing and risk factors for functional changes associated with medical hospitalization in older patients. J Gerontol A Biol Sci Med Sci 65:866–872CrossRefPubMed

Inouye SK, Bogardus ST, Baker DI, Leo-Summers L, Cooney LM (2000) The hospital elder life program: a model of care to prevent cognitive and functional decline in older hospitalized patients. Hospital elder life program. J Am Geriatr Soc 48:1697–1706CrossRefPubMed

Halbreich U, Palter S (1996) Accelerated osteoporosis in psychiatric patients: possible pathophysiological processes. Schizophr Bull 22:447–454CrossRefPubMed

Genant HK, CY W, van Kuijk C, Nevitt MC (1993) Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res 8:1137–1148CrossRefPubMed

Orimo H, Nakamura T, Hosoi T et al (2012) Japanese 2011 guidelines for prevention and treatment of osteoporosis--executive summary. Arch Osteoporos 7:3–20CrossRefPubMedPubMedCentral

10.

Fujiwara S, Nakamura T, Orimo H, Hosoi T, Gorai I, Oden A, Johansson H, Kanis JA (2008) Development and application of a Japanese model of the WHO fracture risk assessment tool (FRAX). Osteoporos Int 19:429–435CrossRefPubMedPubMedCentral

11.

Kanis JA, McCloskey EV, Johansson H, Oden A, Ström O, Borgström F (2010) Development and use of FRAX in osteoporosis. Osteoporos Int 21(Suppl 2):S407–S413CrossRefPubMed

12.

Seichi A, Hoshino Y, Doi T, Akai M, Tobimatsu Y, Iwaya T (2012) Development of a screening tool for risk of locomotive syndrome in the elderly: the 25-question geriatric locomotive function scale. J Orthop Sci 17:163–172CrossRefPubMed

13.

Muramoto A, Imagama S, Ito Z, Hirano K, Tauchi R, Ishiguro N, Hasegawa Y (2013) Threshold values of physical performance tests for locomotive syndrome. J Orthop Sci 18:618–626CrossRefPubMed

14.

Yang S, Shen X (2015) Association and relative importance of multiple obesity measures with bone mineral density: the National Health and nutrition examination survey 2005-2006. Arch Osteoporos 10:14CrossRefPubMed

15.

Erlandson KM, Guaraldi G, Falutz J (2016) More than osteoporosis: age-specific issues in bone health. Curr Opin HIV AIDS 11:343–350CrossRefPubMedPubMedCentral

16.

Halleen JM, Ylipahkala H, Alatalo SL, Janckila AJ, Heikkinen JE, Suominen H, Cheng S, Väänänen HK (2002) Serum tartrate-resistant acid phosphatase 5b, but not 5a, correlates with other markers of bone turnover and bone mineral density. Calcif Tissue Int 71:20–25CrossRefPubMed

17.

Chiliza B, Asmal L, Oosthuizen P, van Niekerk E, Erasmus R, Kidd M, Malhotra A, Emsley R (2015) Changes in body mass and metabolic profiles in patients with first-episode schizophrenia treated for 12 months with a first-generation antipsychotic. Eur Psychiatry 30:277–283CrossRefPubMed

18.

Bak M, Fransen A, Janssen J, van Os J, Drukker M (2014) Almost all antipsychotics result in weight gain: a meta-analysis. PLoS One 9:e94112CrossRefPubMedPubMedCentral

19.

Haupt DW (2006) Differential metabolic effects of antipsychotic treatments. Eur Neuropsychopharmacol 16(Suppl 3):S149–S155CrossRefPubMed

20.

Hummer M, Malik P, Gasser RW, Hofer A, Kemmler G, Moncayo Naveda RC, Rettenbacher MA, Fleischhacker WW (2005) Osteoporosis in patients with schizophrenia. Am J Psychiatry 162:162–167CrossRefPubMed

21.

Halleen JM, Tiitinen SL, Ylipahkala H, Fagerlund KM, Väänänen HK (2006) Tartrate-resistant acid phosphatase 5b (TRACP 5b) as a marker of bone resorption. Clin Lab 52:499–509PubMed

22.

Cavalier E, Bergmann P, Bruyère O et al (2016) The role of biochemical of bone turnover markers in osteoporosis and metabolic bone disease: a consensus paper of the Belgian bone Club. Osteoporos Int 27:2181–2195CrossRefPubMed

Title: Osteopenia and the physical function in Japanese patients with schizophrenia
Authors: Satoru Uchida
Tsuyoshi Ichinose
Yoichi Iizuka
Koichi Okamura
Hitoshi Shitara
Manabu Yamazaki
Kenji Takagishi
Haku Iizuka
Publication date: 01-12-2017
Publisher: Springer London
Published in: Archives of Osteoporosis / Issue 1/2017
Print ISSN: 1862-3522
Electronic ISSN: 1862-3514
DOI: https://doi.org/10.1007/s11657-017-0391-7

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Osteopenia and the physical function in Japanese patients with schizophrenia

Abstract

Summary

Purpose

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Summary

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 1/2017

Relationships among diet, physical activity, and dual plane dual-energy X-ray absorptiometry bone outcomes in pre-pubertalgirls

Increasing hip fracture rates among older adults in Ecuador: analysis of the National Hospital Discharge System, 1999–2016

Exploring methods for comparing the real-world effectiveness of treatments for osteoporosis: adjusted direct comparisons versus using patients as their own control

Pathological fractures in a patient with severe osteomalacia and hyperparathyroidism: a multidisciplinary challenge

Osteoporosis among hospitalized patients with proximal femoral fractures in Assiut University Trauma Unit, Egypt

Comparing self-perceived and estimated fracture risk by FRAX® of women with osteoporosis